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Abstract  
Objective: Insomnia frequently occurs alongside distressing tinnitus, and greater tinnitus 
severity is associated with more sleep disturbance. Insomnia and tinnitus probably share 
common underlying processes and sleep studies show striking similarities between primary 
and tinnitus-related insomnia. This is the first study to evaluate outcomes following 
insomnia-specific Cognitive Behavioural Therapy (CBTi) for tinnitus-related insomnia in a 
‘real world’ clinic. 
Design: Treatment was six-sessions of group-based CBTi. Measures of insomnia, sleep 
diaries, tinnitus distress, psychological distress, anxiety and depression were completed pre-
intervention, post-intervention and at six-weeks follow up. 
Study sample: Participants were 24 adults with chronic, distressing tinnitus and associated 
sleep disturbance. Twenty-two completed treatment. 
Results: CBTi was associated with significant improvements from pre-intervention to post-
intervention maintained at follow up in insomnia, sleep-diary measures, tinnitus distress, 
psychological distress, anxiety and depression, largely maintained at follow-up. Reliable 
improvements were reported in insomnia (by 67% of patients), tinnitus distress (by 50% of 
patients) and psychological distress (by 38% of patients) post-intervention. 
Conclusions: The results suggest that CBTi is associated with reduced insomnia and distress 
for patients reporting chronic and distressing tinnitus with related insomnia. Further research 
into CBTi for this population, using utilizing robust, randomized controlled designs, is 
warranted. 
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Introduction 
Tinnitus is very prevalent, experienced by 10-15% of the population, with significant 
annoyance reported by 1-2% of the population (Baguley et al., 2013). Tinnitus is associated 
with emotional distress, sleep disturbance, and difficulties with auditory perception and 
concentration. Sleep disturbance is the most or second most common problem (Tyler & 
Baker, 1984; Sanchez & Stephens, 1997), reported by 50%-70% of people attending a 
tinnitus clinic (Jakes et al., 1985; Lindberg, et al., 1988). Insomnia in tinnitus has not been 
clearly defined in the literature (McKenna, 2000) but definitions of insomnia secondary to 
health conditions more generally may apply (Espie, et al 2008; Tang, et al., 2012). 
 
A small amount of research has demonstrated a correlation between tinnitus and insomnia, 
although causal pathways have not been demonstrated. Tinnitus severity levels correlate with 
reported sleep disturbance (Schecklmann, et al., 2015; Folmer & Griest, 2000; Herbert et al., 
2011) and quality of life. Polysomnography (PSG) studies show reduced sleep efficiency 
(SE) and total sleep time (TST) and increased sleep onset latency (SOL) and waking after 
sleep onset (WASO) in tinnitus patients, compared to controls (Burgos et al., 2005).  
 
Research comparing patients with tinnitus-related insomnia to patients with primary insomnia 
have shown striking similarities in abnormalities in sleep architecture in both groups. 
Crönlein et al. (2007) found no significant differences between tinnitus-related insomnia and 
primary insomnia patients on objective (EEG/Electroencephalogram, EOG/Electroculogram, 
EMG/Electromyogram, respiration), or subjective (SE) measures, except that tinnitus patients 
had longer subjective SOL. Daytime levels of attention, tiredness and depression rating 
scores were also equivalent. Similar observations were reported by Burgos et al. (2005), and 
both tinnitus-related and primary insomnia groups, reported more subjectively impaired 
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sleep, decreased SE, TST and increased frequency of night time awakenings than healthy 
controls. Additionally, tinnitus patients had increased SOL compared to the other groups and 
a decreased percentage of stage 2 sleep and elevated Rapid Eye Movement (REM) sleep 
density and percentage compared to controls. 
 
When tinnitus-related insomnia patients are compared to healthy controls, differences in 
sleep architecture have been reported.  Attanasio, et al. (2013) found that tinnitus patients had 
less deep (stage 3, 4) and REM sleep than healthy controls, and there was a positive 
correlation between lighter sleep and self-reported tinnitus distress. Herbert, et al. (2011) 
found that tinnitus patients had reduced subjective sleep quality, and reduced TST and 
although this was not supported by PSG, they found lower EEG delta power during Non-
Rapid Eye Movement (NREM) sleep in tinnitus patients.  A few studies, using self-report 
questionnaires, found that tinnitus patients reported poorer sleep quality, increased insomnia-
specific concerns and more anxiety than healthy controls (Crönlein et al., 2016). Overall 
findings suggest that sleep in tinnitus-related insomnia is similar to primary insomnia and 
different from healthy controls. 
 
Researchers have suggested that tinnitus and insomnia may share similar underlying 
processes, including autonomic hyperarousal, reduced serotonin and depression 
(Wallhäusser-Franke et al., 2013; Attanasio et al. 2013; Burgos, et al., 2005). Both conditions 
are associated with high stress levels and so may be triggered by similar life events. 
Alternatively, tinnitus itself may cause insomnia, and clinical observation has found this 
attribution is commonly made by patients. Once triggered, it is possible that tinnitus-related 
insomnia is maintained in the same way as primary insomnia (by cognitive, behavioural, 
attentional and emotional changes). In this case, it may be reasonable to assume that 
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treatments for primary insomnia can apply to tinnitus-related insomnia (Crönlein, et al., 
2007).  
 
Evidence for psychologically-based treatments for tinnitus-related insomnia is scarce. 
Systematic reviews of interventions for tinnitus have not included sleep disturbance as an 
outcome and no trials have specifically investigated tinnitus patients reporting clinical levels 
of insomnia. Interventional research including sleep disturbance as an outcome has used poor 
quality measures or small groups (Lindberg et al, 1989; Kroner-Herwig, et al. 1995; 
Andersson, et al., 2005). Studies of non-sleep specific CBT has shown improvement on sleep 
diaries, a visual analogue scale and sleep subscale of the Tinnitus Questionnaire (Weise, et 
al., 2008; Kaldo, et al., 2007; Seydel, et al., 2010). Two internet-based trials of CBT have 
found that insomnia improves using a standardized measure of insomnia (Weise et al., 2016; 
Jasper et al., 2014)  
 
Cognitive Behavioural Therapy for Insomnia (CBTi) has proven efficacy as treatment for 
primary insomnia with with medium to large effect sizes reported by high-quality systematic 
reviews (Okajima, et al 2011; Morin, et al., 2006). Encouragingly, evidence has shown that 
CBTi is equally effective for insomnia secondary to another health condition (Morin, et al., 
2006), including cancer (Espie, et al., 2008; Savard, et al., 2005) and chronic pain (Tang, 
2009; Jungquist, et al 2010; Jungquist, et al., 2012; Tang et al 2012).  
 
Considering the similarities between tinnitus and chronic pain (Møller, 2007), the findings in 
the pain literature are of particular interest. For example, CBTi leads to improved sleep and 
pain-interference in the long-term, regardless of pain severity (Jungquist, et al., 2010; 
Jungquist, et al., 2012). Tang (2009) argues that, since sleep deprivation reduces tolerance for 
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persistent physical symptoms, and is maintained by independent cognitive-behavioural 
factors (Tang et al., 2012), secondary insomnia requires direct intervention in order to be 
resolved. If pain-related insomnia responds to CBTi, tinnitus-related insomnia may do too, 
but no studies have yet tested this. Our clinic routinely offers cognitive-behavioural therapies 
for tinnitus, and when sleep is a primary issue, we offer CBTi for tinnitus.  
 
Aims and Hypotheses 
This (uncontrolled) study aimed to evaluate the outcomes associated with group-based CBTi 
for patients reporting tinnitus-related insomnia, using reliable change on standardized 
measures as criteria for improvement.  
 
We hypothesised that:  
1. CBTi would be associated with a reliable and clinically significant reduction in sleep 
disturbance, as measured a standardised insomnia questionnaire, and statistically 
significant improvements in sleep, as measured by sleep diaries.  
2. CBTi would be associated with a reliable and clinically significant reduction in 
tinnitus-related distress and general psychological distress. 
3. CBTi would be associated with statistically significant reductions in levels of anxiety 
and depression. 
 
Methods 
Participants 
As this was an evaluation of routine clinical work, eligibility criteria were as follows: 
Participants were 24 adults reporting chronic distressing tinnitus (for six months or longer), 
and sleep disturbance, who had completed medical/audiological examinations, and had been 
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referred to psychology for help with tinnitus. Many reported clinical levels of anxiety and / or 
depression, but this did not affect treatment offered. Exclusion criteria included individuals 
reporting high levels of risk (suicidality, substance misuse or self-harm), or a preference 
against group treatment; individual therapy was offered to people excluded on these grounds.  
 
From March 2016 to April 2017, 204 tinnitus patients were referred to the psychology 
service. Of these, 17 were referred specifically with tinnitus-related insomnia and seven 
others reported insomnia and a preference for sleep-treatment at assessment. All other 
patients were deemed more appropriate for tinnitus-focused (rather than sleep-focused) 
therapy.  
 
Procedures 
Patients referred were assessed by a clinical psychologist within four months (according to a 
routine waiting list). Assessment included clinical interview and standardized outcome 
measures. If significant sleep disturbance was reported, patients were given information 
about the CBTi group and could opt for this or alternative psychological therapy. Waiting 
time from assessment to CBTi varied from one to eight weeks. Three clinical psychologists 
offered CBTi, working in pairs (EM / LM or EM / FV). The treatment manual had been 
developed as part of routine service development, and adherence to the manual / treatment 
integrity was managed via regular team meetings. Treatment completion was regarded as 
attending at least 50% (3 treatment sessions).  
 
Intervention 
CBTi for tinnitus was based on typical CBTi, with six sessions involving sleep diary 
monitoring, time-in-bed restriction, stimulus control, relaxation training, cognitive 
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restructuring and behavioural change. Additional tinnitus-focused elements we also included: 
Psychoeducation about tinnitus, understanding shared processes in tinnitus and insomnia, and 
provision of a night-time sound machine.  
 
Measures 
Routine, standardized outcome questionnaires were completed three times (pre-intervention; 
post-intervention; six-week follow up). A sleep diary was kept every night from 2-weeks 
before session 1 until the final follow up. Demographic information was routinely collected.  
 
Primary Clinical Outcome (Insomnia Severity Index) 
Insomnia Severity Index (ISI), patient version (Bastien, et al., 2001): A 7-item retrospective 
self-report questionnaire on a 5-point Likert scale assessing the nature, severity, and impact 
of insomnia over two weeks. Total scores are: No insomnia (0–7); sub-clinical insomnia (8–
14); moderate insomnia (15–21); severe insomnia (22–28). It has excellent internal 
consistency in patient samples (Cronbach 𝑎 0.91), is sensitive to treatment response, and can 
can show the clinical significance of change (whilst sleep diaries alone can only show 
statistical significance) (Morin et al., 2011). A 6-point reduction has been recommended as 
showing clinically meaningful change in primary insomnia (Yang et al., 2009). 
 
Secondary Clinical Outcomes  
Sleep Measures (Diaries): Sleep diaries are an effective measure of statistically significant 
changes in sleep. Patients recorded the following every day: 
Sleep Onset Latency (SOL), Wake-time After Sleep Onset (WASO), Total Sleep Time 
(TST), Time spent In Bed (TIB). From this a key measure of insomnia, Sleep Efficiency (SE) 
is calculated (SE = TST / TIB x 100).  
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Tinnitus-related Distress: The Tinnitus Questionnaire (TQ) is a self-report questionnaire 
with 41 items scored 0 – 2 (Hallam, 1996). A reliable change index (RCI) of 11.08 was used. 
This had been established previously in our population using the Jacobson & Truax formula 
(1991) (see McKenna, Marks & Vogt., 2017). There is high test-retest reliability (r =.94) and 
internal consistency (α =.93) (Hiller et al., 1994).  
General Psychological Distress: The Clinical Outcome in Routine Evaluation - Outcome 
Measure (CORE-OM) (Evans, et al., 2000) assesses general psychological state through 34-
items rated on a 0 to 4 scale. It can be scored as two scales: “risk” and “psychological 
distress”. The non-risk scale (CORE-NR) is the mean of the 28 non-risk items multiplied by 
10 (McKenna et al., 2017). An average score of 10 or more is ‘clinically significant’ and the 
reliable change criterion is ≥5. When a subject’s score decreases by ≥5 and moves from the 
clinical to the non-clinical range (i.e. from > 10 to < 10) the individual is regarded as being 
reliably and significantly improved. It is an appropriate measure of distress in tinnitus 
patients (Handscomb et al., 2016).  
Depression: The Patient Health Questionnaire-9 (PHQ-9) has nine items on a 0 to 3 scale, 
measuring depressive symptoms over the preceding two weeks (Kroenke, et al., 2001). Total 
scores range from 0 to 27. Scores of 10 and above indicate the presence of clinical 
depression. 
Anxiety: The GAD7 assessed anxiety via seven items rated on a similar 0 to 3 scale as the 
PHQ9 (Spitzer, et al., 2006). Total scores range from 0 to 21 and scores of 8 and above 
indicate the presence of clinical anxiety.  
 
Ethics 
The Hospital Trust gave permission for publication of this report as an evaluation of routine 
clinical work.  
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Statistical analyses 
Summaries are presented as means [SE] and n (%), as appropriate. Repeated measures 
ANOVA with Bonferoni corrections were used to assess the primary outcome of Insomnia 
Severity (ISI) and secondary outcomes of Sleep Efficiency (SE), Sleep-onset latency (SOL), 
Wakefulness after sleep-onset (WASO), Total Sleep Time (TST), tinnitus distress (TQ), 
psychological distress (CORE-OM), Anxiety (GAD-7) and Depression (PHQ-9). Comparison 
of pre-post and pre-follow-up was made separately. Effect sizes for repeated measures 
designs are Cohen’s d, calculated with Morris (2008).  
 
Results 
Of the 24 patients included, 22 (92%) completed treatment (two dropped out, one due to 
illness, one due to other demands). Fifteen attended follow-up. Of completed questionnaires, 
missing data was minimal on outcome variables (<4%). Data was missing for seven 
participants at the final session and for nine at follow up (due to non-attendance of treatment 
completers).  Missing data was consistent with the assumption of Missing at Random (MAR) 
and hence handled using multiple imputation (MI) using primary outcome and process 
variables (Ware, et al. 2012). 
 
Patient characteristics 
Participants’ mean age was 55.71 [12.14] years (range 35 to 79). Gender was equally 
distributed (50% male). All patients had chronic tinnitus (present for at least three months) by 
the commencement of therapy, with an average of 23.17 months (range 4 to 42 months). The 
average group size was 8 people (range 7 to 9). Baseline mean TQ score was (46.25 [3.05]), 
in the third quartile of scores observed in a tinnitus clinic (moderate to severe distress). Table 
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1 summarizes treatment effect on primary outcomes and Table 2 summarizes treatment effect 
on secondary outcomes.  
 
<INSERT TABLE 1 NEAR HERE> 
Table 1. Effect of treatment on primary outcomes: Insomnia and sleep diaries  
 
Primary Outcomes 
Repeated-measures ANOVAs showed improvements across a range of insomnia measures:  
Insomnia Severity Index (ISI): Levels of insomnia changed across the intervention. It 
decreased significantly from pre- to post-intervention, by 10.1 points (p<.01) and maintained 
a reduction at follow-up (p<0.05). Sixty-seven percent (66.7%) experienced reliable 
improvement (i.e. a reduction ≥ 6) from pre- to post-intervention, and 54.2% from pre-
intervention to follow-up. 
Sleep efficiency (SE) increased significantly during the intervention. Sleep efficiency 
increased by 12.7% from pre- to post-intervention (p<0.01) and maintained a similar 
improvement at follow-up (p<0.05). 
Sleep-onset latency (SOL) changed significantly during the intervention. Participants fall 
asleep 11.7 minutes sooner post-intervention, but the difference was not significant. By 
follow-up sleep onset reduced by a further 8.5 minutes compared to post-intervention, which 
was significant (p<0.01). 
Wakefulness after sleep-onset (WASO) changed significantly across the intervention. It 
decreased post-intervention by 20.9 minutes (p<0.05). However, follow-up wakefulness was 
not significantly different to either pre-intervention or post-intervention (p>.05). 
Time in bed (TIB) changed significantly as part of the intervention. It decreased by 60.5 
minutes from pre- to post-intervention (p<0.01) but increased again by 35.1 minutes at 
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follow-up (p<0.01) compared to post-intervention. 
Total sleep time (TST) did not change significantly during the intervention. 
 
Secondary Outcomes 
Tinnitus-related distress (TQ): Tinnitus distress decreased significantly from pre- to post-
intervention, maintained at follow up, (see table 2) demonstrating sustained significant 
improvement. Fifty percent experienced reliable improvement (i.e. a reduction >11.08) from 
pre- to post-intervention, and 41.7% from pre-intervention to follow-up.  
Psychological distress (CORE-NR): Psychological distress decreased significantly from pre 
to post-intervention and to follow-up (see table 2). Reliable improvement post-intervention 
was observed in 37.5% of participants, and by 41.7% at follow-up. Of those who were in a 
clinically significant state of psychological distress (i.e. CORE>-NR >10) before the 
intervention, 41.7% were in a non-clinical range post-intervention and 41.1% were in a non-
clinical range at follow-up. Both reliable change and moving into remission (i.e. from above 
to below the clinical cut-off point of 10) was reported by 29.2% of the sample post-
intervention and 25% of the sample by follow-up.  
Anxiety and Depression (PHQ9, GAD7): The same pattern of reduced symptomatology was 
found on specific measures of anxiety and depression (see table 2). Both depression (PHQ9) 
and anxiety (GAD7) decreased significantly from pre- to post-intervention, but this decrease 
was only sustained for depression.  
 
<INSERT TABLE 2 NEAR HERE> 
Table 2. Effect of treatment on secondary outcomes: Tinnitus and Psychological 
Distress  
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Discussion 
This is the first ever study to report on outcomes associated with insomnia-specific CBT 
(CBTi) for patients with tinnitus-related insomnia. As hypothesized, CBTi was associated 
with improvement across a range of well-established sleep outcomes, with 66.7% reporting 
reliable improvement on the ISI post-treatment, sustained by 54.2% at follow-up. 
There were also statistically significant improvements seen in SE and SOL, TIB and WASO 
alongside significant reductions in tinnitus-related and psychological distress, anxiety and 
depression.  
 
Findings are clinically important in light of the evidence that sleep disturbance is prevalent in 
tinnitus, with delayed Sleep Onset Latencies (SOL), increased Wake Time After Sleep Onset 
(WASO), reduced Sleep Efficiency (SE) and Total Sleep Time (TST) (Burgos et al., 2005; 
Cronlein et al., 2016). The association of CBTi with changes on all of these aspects of sleep 
(excepting  TST and WASO at follow-up) is encouraging, as are the findings of moderate-to-
large effect sizes in the primary outcomes of interest (ISI, SOL and SE). This is in line with 
trials of CBTi for insomnia that is primary, or secondary to other health conditions, including 
chronic pain. Meta-analyses tend to report effect sizes as greater for SOL than TST (e.g. 
Harvey & Tang, 2003), and single RCTs of CBTi for illness-related insomnia report 
significant improvements in SE, SOL and WASO, but non-significant increases in TST (e.g. 
in chronic pain – Jungquist et al., 2010; cancer - Espie, et al., 2008). This may be because 
longer follow-up periods are required to see change in TST, as CBTi focuses on sleep 
consolidation before increasing sleep time.  
 
Patients in this evaluation also reported significantly lower tinnitus-related and psychological 
distress following treatment. Reliable improvements in tinnitus distress were reported by 
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50% of patients and in psychological distress by 37.5% of patients post-intervention, with 
such changes largely sustained by follow-up. Again, this indicates potential clinical 
importance, with the percentage of improvement in line with other tinnitus-specific 
psychological treatments, including those offered by our clinic, such as Mindfulness Based 
Cognitive Therapy for tinnitus (McKenna, Marks & Vogt, 2017; McKenna et al., 2017). 
Improvement was also seen in anxiety and depression, although only maintained in 
depression. Improvements in multiple domains are noteworthy for two reasons: Insomnia is 
associated with more severe tinnitus (e.g. Schecklmann, et al., 2015; Folmer & 2000; 
Herbert, et al., 2011); and tinnitus can be problematic even without sleep disturbance 
(Baguley, et al., 2013). Any treatment in a clinical setting should be able to improve tinnitus 
and distress as well as sleep, and these initial findings for CBTi warrant further investigation 
in this area.  
 
CBTi has been thoroughly tested and described across the literature, and found to be 
acceptable and replicable (Harvey & Tang, 2003). This appeared to be reflected in our high 
(92%) completion rates. Attendance at a follow-up appointment was lower, possibly since 
this additional session was a ‘booster’ rather than further treatment, potentially reducing 
motivation to attend. As our treatment follows established CBTi protocols, it should be easily 
replicable, with appropriate training and supervision.  
 
Strengths of this study are the naturalistic design with minimal exclusion criteria and all 
patients reporting chronic tinnitus and insomnia, severe enough to seek treatment at a tertiary 
care level. There are also important limitations. It is a non-controlled evaluation of routine 
clinical practice, with a small sample size, missing data and a relatively short follow-up 
period of 6 weeks. There may also be a source of bias, with self-reported data being collected 
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as part of routine care, by the treating clinicians and not by independent researchers.  To 
minimize bias, most data-entry was completed by a team member not involved in treatment 
delivery. It is noteworthy that, although tinnitus can improve over time (e.g. during a waiting 
period; Hesser et al., 2011), improvements are unlikely to be of the sizes seen here over just 8 
weeks (McKenna, et al., 2017). Similarly, chronic insomnia rarely improves spontaneously 
(Tang, 2009). Without a control group, it is difficult to ascertain the specific effects of CBTi, 
but the moderate to large effect sizes across measures, and sizeable percentages of patients 
showing reliable improvement are encouraging, and in line with other tinnitus treatments 
previously tested within our population (McKenna, Marks & Vogt, 2017; McKenna et al., 
2017). Even so, we recommend that these results be interpreted with caution.  
 
Implications  
This study offers a new addition to the literature on tinnitus and insomnia. CBTi was 
associated with improved sleep, tinnitus and distress, in line with theory and evidence for 
tinnitus-related insomnia. This finding adds to evidence that insomnia secondary to tinnitus 
may be phenomenologically and psychologically similar to primary insomnia, and so 
responsive to insomnia-focused cognitive and behavioural treatment.  
 
The findings could have meaningful clinical implications, and it is clearly necessary to test 
this treatment approach in a rigorous way with larger samples and randomized controlled 
design. Only when CBTi is compared to control groups, including currently available 
treatment, will it be possible to say whether this treatment leads directly to the improvements 
shown here. Further research is warranted considering the pernicious and debilitating effects 
of insomnia-related tinnitus. As this study tentatively suggests, it may be possible for tinnitus 
patients with insomnia to develop better sleep through the process of CBTi.  
Marks: CBTi for tinnitus: Pre-Proof 16 
 
Disclosure Statement  
The authors report no conflicts of interest. No funding was provided for this study. 
 
Geolocation information 
This study was based in London, UK.  
 
Acknowledgements 
We would like to thank the patients attending our service and for the Hospital for supporting 
this evaluation process.  
 
 
 
References 
 
1. Andersson, G., Porsaeus, D., Wiklund, M., Kaldo, V. & Larsen, H. C. (2005) 
Treatment of tinnitus in the elderly: a controlled trial of cognitive behaviour therapy. 
International Journal of Audiology, 44: 671 – 675. 
2. Attanasio, G., Russo, F. Y., Roukos, R.  Covelli, E., Cartocci, G. Saponara, M. (2013) 
Sleep architecture variation in chronic tinnitus patients. Ear & Hearing, 34 (4): 503-
507. 
3. Baguley D, Andersson G, McFerran D, McKenna L. Hyperacusis. Tinnitus: A 
Multidisciplinary Approach, Second Edition. 2013 (p.8-12). 
4. Bastien, C.H., Vallières, A. and Morin, C.M., 2001. Validation of the Insomnia 
Severity Index as an outcome measure for insomnia research. Sleep medicine, 2(4), 
pp.297-307. 
Marks: CBTi for tinnitus: Pre-Proof 17 
5. Burgos, I., Feige, B., Hornyak, M., Harter, M., Weske-Heck, G., Voderholzer, U.  & 
Riemann, D. (2005) Chronic tinnitus and associated sleep disturbances.  Somnologie, 
9 (3) 133-138. 
6. Crönlein, T., Langguth, B., Pregler, M., Kreuzer, P.M., Wetter, T.C. and 
Schecklmann, M. (2016). Insomnia in patients with chronic tinnitus: Cognitive and 
emotional distress as moderator variables. Journal of psychosomatic research, 83, 
pp.65-68. 
7. Crönlein, T., Langguth, B., Geisler, P. & Hajak, G. (2007) Tinnitus and insomnia. 
Progress in Brain Research, 166: 227-33. 
8. Morris, S. B. (2008). Estimating Effect Sizes From Pretest-Posttest-Control Group 
Designs. Organizational Research Methods, 11(2), 364-386.  
9. Espie, C.A., Fleming, L., Cassidy, J., Samuel, L., Taylor, L.M., White, C.A., Douglas, 
N.J., Engleman, H.M., Kelly, H.L. & Paul, J. (2008). Randomized controlled clinical 
effectiveness trial of Cognitive Behavioural Therapy compared with treatment as 
usual for persistent insomnia in patients with cancer. Journal of Clinical Oncology 
28(28): 4651-4658. 
10. Evans, J., Margison, F., Barkham, M., Audin, K., Connell, J., & McGrath, G. (2000). 
CORE: clinical outcomes in routine evaluation. Journal of Mental Health, 9(3), 
pp.247-255. 
11. Folmer, R. L. &  Griest, S. E. (2000) Tinnitus and insomnia. American Journal of 
Otolaryngology, 21 (5): 287-93. 
12. Hallam, R.S., (1996). Manual of the tinnitus questionnaire (TQ). London: 
Psychological Corporation. 
13. Hallam, R., Jakes, S. & Hinchcliffe, R. (1988) Cognitive variables in tinnitus 
annoyance. British Journal of Clinical Psychology, 27 213-222. 
Marks: CBTi for tinnitus: Pre-Proof 18 
14. Handscomb, L., Hall, D.A., Hoare, D.J. and Shorter, G.W. (2016). Confirmatory 
factor analysis of Clinical Outcomes in Routine Evaluation (CORE-OM) used as a 
measure of emotional distress in people with tinnitus. Health and quality of life 
outcomes, 14(1), p.124. 
15. Harvey, A.G. and Tang, N.K. (2003). Cognitive behaviour therapy for primary 
insomnia: can we rest yet?. Sleep medicine reviews, 7(3), pp.237-262. 
16. Hébert, S., Fullum, S., & Carrier, J. (2011). Polysomnographic and quantitative 
electroencephalographic correlates of subjective sleep complaints in chronic tinnitus. 
Journal of Sleep Research. 20, pp. 38-44. 
17. Hesser, H., Weise, C., Westin, V.Z. and Andersson, G. (2011) A systematic review 
and meta-analysis of randomized controlled trials of cognitive–behavioral therapy for 
tinnitus distress. Clinical psychology review, 31(4), pp.545-553. 
18. Hiller, W., Goebel, G. and Rief, W. (1994) Reliability of self‐rated tinnitus distress 
and association with psychological symptom patterns. British Journal of Clinical 
Psychology, 33(2), pp.231-239. 
19. Jakes, S.C., Hallam, R.S., Chambers, C. & Hinchcliffe, R. (1985) A factor analytical 
study of tinnitus complaint behavior. International Journal of Audiology 24(3): 195 – 
206.  
20. Jasper K, Weise C, Conrad I, Andersson G, Hiller W, Kleinstäuber M. Internet-based 
guided self-help versus group cognitive behavioral therapy for chronic tinnitus: A 
randomized controlled trial. Psychother Psychosom 2014;83:234-246. 
21. Jungquist, C.R., O-Brien, C., Matteson-Rusby, S., Smith, M.T., Pigeon, W.R., Xia, Y, 
Lu, N., Perlis, M.L. (2010) The efficacy of cognitive-behavioural therapy for 
insomnia in patients with chronic pain. Sleep Medicine 11(3): 302 – 309. 
Marks: CBTi for tinnitus: Pre-Proof 19 
22. Jungquist, C.R., Tra, Y., Smith, M.T., Pigeon, W.R., Matteson-Rusby, S., Xia, Y., 
Perlis, M.L. (2012) The durability of Cognitive Behavioural Therapy for insomnia in 
patients with chronic pain. Sleep Disorders ID 679648. 
23. Kaldo, V., Cars, S., Rahnert, M., Larsen, H. C. & Andersson, G. (2007) Use of a self-
help book with weekly therapist contact to reduce tinnitus distress: A randomized 
controlled trial. J Psychosomatic Research, 63, 195-202. 
24. Kroenke, K., Spitzer, R.L. and Williams, J.B. (2001) The PHQ‐9. Journal of general 
internal medicine, 16(9), pp.606-613. 
25. Kroenke, K., & Spitzer, R. L. (2002). The PHQ-9: a new depression diagnostic and 
severity measure. Psychiatric annals, 32(9), 509-515. 
26. Kroner-Herwig, B., Hebing, G., Van Rijn-Kalkmann, U., Frenzel, A., Schilkowsky, 
G. & Esser, G. (1995) The management of chronic tinnitus – Comparison of a 
cognitive-behavioural group training with yoga. Journal of Psychosomatic Research, 
39: (2) 153-165 
27. Lindberg, P., Scott, B., Melin, L. & Lyttkens, L. (1988) Behavioural therapy in the 
clinical management of tinnitus. British Journal of Audiology 22(4): 265-272. 
28. Lindberg, P., Scott, B., Melin, L.  & Lyttkens, L. (1989) The psychological treatment 
of tinnitus: An experimental evaluation. Behavior Research & Therapy, 27:6 593-603. 
29. Martinez-Devesa, P., Perera, R., Theodoulou, M., Waddell, A. (2010) Cognitive 
behavioural therapy for tinnitus. Cochrane Database of Systematic Reviews, Issue 9. 
Art. No.: CD005233. DOI: 10.1002/14651858.CD005233.pub3 
30. McKenna, L., Marks, E.M. and Vogt, F. (2017) Mindfulness-Based Cognitive 
Therapy for Chronic Tinnitus: Evaluation of Benefits in a Large Sample of Patients 
Attending a Tinnitus Clinic. Ear and Hearing. 
Marks: CBTi for tinnitus: Pre-Proof 20 
31. McKenna, L. (2000) Tinnitus and insomnia. In R. Tyler (ed) Tinnitus Handbook. 
Singular: San Diego.  
32. McKenna, L., Marks, E., Hallsworth, C.A. and Schaette, R. (2017) Mindfulness-
Based Cognitive Therapy as a Treatment for Chronic Tinnitus: A Randomized 
Controlled Trial. Psychotherapy and psychosomatics, 86(6), pp.351-361. 
33. Møller, A. R. (2007). Tinnitus and pain. Progress in Brain Research, 166, 47-53.  
34. Morin, C.M. (2003) Measuring outcomes in randomized clinical trials of insomnia 
treatments. Sleep Med Rev 7; 263-79 (pg.  
35. Morin CM; Belleville G; Bélanger L; Ivers H. The insomnia severity index: 
psychometric indicators to detect insomnia cases and evaluate treatment response. 
SLEEP 2011;34(5):601-608. 
36. Morin, C. M., Bootzin, R. R., Buysse, D. J., Edinger, J. D., Espie, C. A., & Lichstein, 
K. L. (2006). Psychological and behavioral treatment of insomnia: update of the 
recent evidence (1998-2004). SLEEP-NEW YORK THEN WESTCHESTER-
, 29(11), 1398. 
37. Okajima, I., Komada, Y., Inoue, Y. (2011) A meta-analysis on the treatment 
effectiveness of cognitive behavioural therapy for primary insomnia. Sleep and 
Biological Rhythms 9: 24-34. 
38. Sanchez, L. & Stephens, D. (1997) A tinnitus problem questionnaire in a clinical 
population.  Ear and Hearing, 18, (3) 210-217. 
39. Savard, J., Simard, S., Ivers, H. and Morin, C.M. (2005) Randomized study on the 
efficacy of Cognitive-Behavioural Therapy for insomnia secondary to breast cancer, 
part I: Sleep and Psychological Effects. Journal of Clinical Oncology 23(25): 6083-
6096. 
Marks: CBTi for tinnitus: Pre-Proof 21 
40. Schecklmann, M., Pregler, M., Kreuzer, P.M., Poeppl, T.B., Lehner, A., Crönlein, T., 
Wetter, T.C., Frank, E., Landgrebe, M. and Langguth, B. (2015) Psychophysiological 
associations between chronic tinnitus and sleep: a cross validation of tinnitus and 
insomnia questionnaires. BioMed research international, 2015.  
41. Seydel, C., Haupt, H., Szczepek, A., Klapp, B. & Mazurek, B. (2010) Long term 
improvement in tinnitus after modified tinnitus retraining therapy enhanced by a 
variety of psychological approaches. Audiology & Neurootology, 15; 69-80. 
42. Spitzer, R.L., Kroenke, K., Williams, J.B. and Löwe, B. (2006). A brief measure for 
assessing generalized anxiety disorder: the GAD-7. Archives of internal 
medicine, 166(10), pp.1092-1097. 
43. Tang, N.K.Y. (2009). Cognitive Behavioural Therapy for sleep abnormalities of 
chronic pain patients. Current Rheumatology Reports 11:451-460. 
44. Tang, N.K.Y., Goodchild, C.E., Hester, J., Salkovskis, P.M. (2012). Pain-related 
insomnia versus primary insomnia: A comparison study of sleep pattern, psycholgical 
characteristics and cognitive-behavioural processes. Clin J Pain 28: 428 – 436. 
45. Tyler, R. & Baker, L. (1983) Difficulties experienced by tinnitus sufferers. Journal of 
Speech and Hearing Disorders, 48, 150-154.  
46. Wallhausser-Franke, E., Schredl, M. & Delb, W. (2013) Tinnitus and insomnia: is 
hyperarousal the common denominator? Sleep Medicine Reviews, 17 (1): 65-74 
47. Ware JH, Harrington D, Hunter DJ, D’Agostino RB. (2012) Missing Data. N Engl J 
Med. 367(14):1353–4. doi: 10.1056/NEJMsm1210043 
48. Weise, C., Heinecke, K. & Rief, W. (2008) Biofeedback-Based Behavioral Treatment 
for Chronic Tinnitus: Results of a randomized Controlled Trial. J. Consulting & 
Clinical Psychology, 76:6 1046-1057. 
Marks: CBTi for tinnitus: Pre-Proof 22 
49. Weise C., Kleinstäuber, M., Andersson, G. Internet-delivered cognitive-behavior 
therapy for tinnitus: A randomized controlled trial. Psychosom Med 2016;78:501-510. 
50. Yang, M., Morin, C.M., Schaefer, K., Wallenstein, G.V. (2009). Interperting scroe 
differences in the Insomnia Severity Index: using health-related outcomes to define 
the minimally important difference. Current Medical Research Opinion 25(10): 2487 
– 94. 
  
Marks: CBTi for tinnitus: Pre-Proof 23 
Table 1. Effect of treatment on primary outcomes: Insomnia and Sleep Diaries  
 
 Pre-
intervention 
Post-
Intervention 
6-week follow-
up 
ANOVA, F, p-
value 
ISI, mean [SE] 
 
Effect Size – Cohen’s d 
 
Reliable Improvement 
(reduction ≥ 6) n (%) 
 20.2 [0.9] a 
  
- 
 
 
12.1 [1.1] b 
  
d=1.36 
 
66.7% (16) 
 
12.3 [1.2] b 
 
d=1.19 
 
54.2% (13) 
(2, 46) 31.780, 
p<.01 
SE, mean [SE] 
 
Effect Size – Cohen’s d 
 
67.1 [2.7] a 
 
- 
79.8 [2.8] b 
 
d=0.80 
76.7 [2.6] b 
 
d=0.62 
 
 
(2, 46) 11.196, 
p<.01 
TIB, mean [SE] 
 
Effect Size – Cohen’s d 
 
482.7 [13.1] a 
  
- 
 
422.2 [11.9] b 
  
d=0.96 
 
457.3 [9.3] a 
 
d=0.31 
 
(2, 46) 11.883, 
p<.01 
TST, mean [SE] 
 
Effect Size – Cohen’s d 
 
 329.6 [14.2] 
  
- 
331.8 [13.0] 
  
d=0.03 
 
347.2 [12.9] 
 
d=0.21 
 
(2, 46) 0.928, n.s.  
SOL, mean [SE] 
 
Effect Size – Cohen’s d 
45.4 [6.5] a 
  
- 
 
33.7 [6.8] a 
  
d=0.42 
25.2 [4.2] b 
 
d=0.59 
 
(2, 46) 6.026, 
p<.01 
WASO, mean [SE] 
 
Effect Size – Cohen’s d 
 
 46.5 [7.0] a 
  
- 
 
25.6 [5.5] b 
  
d=0.49 
 
32.3 [6.1] a 
 
d=0.34 
 
(2, 46) 4.865, 
p<.05 
 
n.s. = not significant at p >0.05; a b Time points with similar superscripts do not differ (p > 
0.05). 
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Table 2. Effect of Treatment on Secondary Outcomes: Tinnitus and Psychological 
Distress  
 Pre-
intervention 
 
Post-
intervention  
6-week 
follow-up  
ANOVA, F, 
p-value 
Tinnitus distress, mean [SE] 
 
Effect Size to Pre-intervention – 
Cohen’s d 
 
Reliable Improvement (reduction ≥ 
11.47) % (n) 
46.2 [3.0] a 
 
- 
 
 
- 
 
32.1 [2.8] c  
 
0.91 
 
 
50.0% (12) 
36.2 [2.8] b 
 
0.62 
 
 
41.7% (10) 
(2, 46) 
13.749, 
p<.01 
Psychological distress, mean [SE] 
 
Effect Size to Pre-intervention – 
Cohen’s d 
 
Reliable Improvement (reduction ≥ 
5) n (%) 
 
Remission (reduction from >10 to 
≤10) n (%) 
 
Reliable recovery (reliable 
improvement and remission) n(%) 
14.7 [1.4] a  
 
 
- 
 
 
- 
 
 
- 
 
 
- 
10.8 [1.3] b 
 
 
0.72 
 
 
37.5% (9) 
 
 
41.7% (10) 
 
 
29.2% (7) 
10.6 [1.3] b 
 
 
0.62 
 
 
41.7% (10) 
 
 
37.5% (9) 
 
 
25% (6) 
(2, 46) 7.86, 
p<.01 
Symptoms depression, mean [SE] 
 
Effect Size to Pre-intervention – 
Cohen’s d 
12.3 [1.1] a 
 
- 
 
7.6 [1.2] b 
 
0.93 
8.6 [1.1] b 
 
0.58 
(2, 46) 9.751, 
p<.01 
Symptoms Anxiety, mean [SE] 
 
Effect Size to Pre-intervention – 
Cohen’s d 
9.5 [0.97] a 
 
- 
6.7 [1.2] b 
 
0.69 
7.3 [1.1] a 
 
0.43 
(2, 46) 5.353, 
p<.01 
n.s. = not significant at p >0.05; a b Time points with similar superscripts do not differ (p > 
0.05). 
 
 
 
  
 
